CARE Ratings Intrinsic Value
CARE Ratings (CARERATING) median intrinsic value is ₹622.00 from 9 valuation models (range ₹332–₹1152), vs current price ₹1658.80 — -62.5% downside (Trading Above Calculated Value), margin of safety -100.0%. Also explore CARERATING share price data to track price trends across different timeframes.
CARERATING Valuation Methods Summary — DCF, Graham Number & P/E
CARE Ratings intrinsic value across 9 models vs current price ₹1658.80 — upside/downside and value range per method. Browse CARERATING balance sheet details for revenue, profit, balance sheet and cash flow data.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹843.84 | ₹675.07 - ₹1012.61 | -49.1% | EPS: ₹70.32, Sector P/E: 12x |
| Book Value Method | asset | ₹331.76 | ₹298.58 - ₹364.94 | -80.0% | Book Value/Share: ₹311.00, P/B: 0.8x |
| Revenue Multiple Method | revenue | ₹497.64 | ₹447.88 - ₹547.40 | -70.0% | Revenue/Share: ₹194.67, P/S: 1.0x |
| EBITDA Multiple Method | earnings | ₹663.52 | ₹597.17 - ₹729.87 | -60.0% | EBITDA: ₹308.00Cr, EV/EBITDA: 5x |
| Simple DCF (5Y) | dcf | ₹663.52 | ₹530.82 - ₹796.22 | -60.0% | CF Growth: 9.4%, Discount: 15% |
| PEG Ratio Method | growth | ₹497.64 | ₹447.88 - ₹547.40 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹579.44 | ₹521.50 - ₹637.38 | -65.1% | Revenue Growth: 6.0%, Adj P/E: 8.2x |
| ROE Based Valuation | profitability | ₹1152.00 | ₹1036.80 - ₹1267.20 | -30.6% | ROE: 23.2%, P/E Multiple: 16x |
| Graham Defensive Method | conservative | ₹622.00 | ₹559.80 - ₹684.20 | -62.5% | EPS: ₹70.32, BVPS: ₹311.00 |
CARERATING Intrinsic Value vs Market Price — All Valuation Models
CARE Ratings fair value range ₹332–₹1152 vs current market price ₹1658.80 across 9 valuation models. For current market price and key ratios, visit CARERATING screener.
CARERATING Intrinsic Value Analysis — Undervalued or Overvalued?
CARE Ratings median intrinsic value ₹622.00, current price ₹1658.80 — Trading Above Calculated Value by 62.5%, margin of safety -100.0%.
What is the intrinsic value of CARERATING?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of CARE Ratings (CARERATING) is ₹622.00 (median value). With the current market price of ₹1658.80, this represents a -62.5% variance from our estimated fair value.
The valuation range spans from ₹331.76 to ₹1152.00, indicating ₹331.76 - ₹1152.00.
Is CARERATING undervalued or overvalued?
Based on our multi-method analysis, CARE Ratings (CARERATING) appears to be trading above calculated value by approximately 62.5%.
CARERATING Financial Health — Key Ratios vs Industry Benchmarks
CARE Ratings financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 15.39 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 23.2% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
| Operating Margin | 46.0% | Industry Standard: 20%+ | Above 20% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.53x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
CARERATING Cash Flow Quality — Operating & Free Cash Flow
CARE Ratings operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹123 Cr | ₹94 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹91 Cr | ₹72 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹82 Cr | ₹82 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹68 Cr | ₹55 Cr | Positive Free Cash Flow | 8/10 |
| March 2021 | ₹86 Cr | ₹67 Cr | Positive Free Cash Flow | 8/10 |